China Health Group Limited (CHG, Stock Code: 673) issued an update related to the auditor’s disclaimer of opinion on the Company’s consolidated financial statements for the year ended 31 March 2025. The Company indicated that it continues to address liquidity concerns and is implementing measures to resolve the going concern issue.
CHG has completed several financing initiatives, including subscriptions and a rights issue, which provided aggregate net proceeds of approximately HK$80.9 million in October 2025. The Board is also negotiating to renew the Group’s bank borrowing of approximately HK$5.4 million as at 31 March 2025 and targets finalizing these negotiations by the end of the first quarter of 2026.
The Company plans to provide updates every three months from 23 January 2026 until the auditor’s disclaimer is resolved. Shareholders and investors are advised to remain cautious when dealing in the Company’s securities.